CONTACT US: Contact info
|
Citation |
Haveman-Gould B, Newman C. JAAPA 2018; 31(11): 21-24. |
|
Affiliation |
Bradley Haveman-Gould practices neurology at Mercy Health Physician Partners in Grand Rapids, Mich., is an adjunct faculty member in the PA program at Drexel University in Philadelphia, Pa., and is an assistant clinical affiliate faculty member in the PA program at Grand Valley State University in Grand Rapids. Chelsea Newman is a student in the PA program at Drexel University. The authors have disclosed no potential conflicts of interest, financial or otherwise. |
|
Copyright |
(Copyright © 2018, American Academy of Physicians Assistants) |
|
DOI |
|
PMID |
30303829 |
|
Abstract |
Post-traumatic stress disorder (PTSD) affects about 20% of US military veterans and is a major cause of mortality in these men and women. The incidence of PTSD has persisted over the last decade with the Iraq and Afghanistan wars, yet treatment and adherence remain inadequate in part due to clinician lack of knowledge about cognitive processing therapy and prolonged exposure, the proven gold standards in treatment. This article reviews the most current and successful PTSD treatment options and identifies risk factors for patient nonadherence in hopes of reducing the rate of veteran suicide related to PTSD. Language: en |